Table 1.
Species | Efflux pump | Gene names | Gene annotation | Major substrates | Reference |
---|---|---|---|---|---|
Burkholderia cenocepacia | |||||
RND-1 | NA | BCAS0591–BCAS0593 | Non-detectable | Buroni et al. (2009) | |
RND-3 | NA1 | BCAL1674–BCAL1676 | Nalidixic acid, ciprofloxacin, tobramycin, chlorhexidine3 | Buroni et al. (2009, 2014), Coenye et al. (2011) | |
RND-4 | NA2 | BCAL2820–BCAL2822 | Aztreonam, chloramphenicol, fluoroquinolones, tobramycin | Bazzini et al. (2011b) | |
RND-8 | NA | BCAM0925–BCAM0927 | Tobramycin3 | Buroni et al. (2014) | |
RND-9 | NA | BCAM1945–BCAM1947 | Tobramycin3, chlorhexidine3 | Coenye et al. (2011), Buroni et al. (2014) | |
RND-10 | ceoAB-opcM4 | BCAM2551–BCAM2549 | Chloramphenicol, fluoroquinolones, trimethoprim | Nair et al. (2004) | |
B. pseudomallei | |||||
AmrAB-OprA | amrAB-oprA | BPSL1804–BPSL1802 | Aminoglycosides, macrolides, cethromycin | Moore et al. (1999), Mima et al. (2011) | |
BpeAB-OprB | bpeAB-oprB | BPSL0814–BPSL0816 | Chloramphenicol, fluoroquinolones, macrolides, tetracyclines5 | Chan et al. (2004), Mima and Schweizer (2010) | |
BpeEF-OprC | bpeEF-oprC | BPSS0292–BPSS0294 | Chloramphenicol, fluoroquinolones, tetracyclines, trimethoprim6 | Kumar et al. (2006), Schweizer (2012a,b) | |
B. thailandensis | |||||
AmrAB-OprA | amrAB-oprA | BTH_I2445–BTH_I2443 | Aminoglycosides, macrolides, tetracyclines | Biot et al. (2013) | |
BpeAB-OprB | bpeAB-oprB | BTH_I0680–BTH_I0682 | Tetracyclines | Biot et al. (2013) | |
BpeEF-OprC | bpeEF-oprC | BTH_II2106–BTH_II2104 | Chloramphenicol, fluoroquinolones, tetracyclines, trimethoprim/sulfamethoxazole | Biot et al. (2011, 2013) | |
B. vietnamiensis | |||||
AmrAB-OprM | amrAB-oprM | Bcep1808_1574–Bcep1808_1576 | Aminoglycosides | Jassem et al. (2014) |
NA, not applicable
1Corresponds to B. pseudomallei amrAB-oprA
2Corresponds to B. pseudomallei bpeAB-oprB
3Sessile (biofilm grown) cells only
4Corresponds to B. pseudomallei bpeEF-oprC
5Low-level resistance in de-repressed (ΔbpeR) strains
6High-level resistance in regulatory mutants, e.g., bpeT carboxy-terminal mutations